Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Diarrhea × Fulvestrant × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 292 Neoplasm Metastasis 36 Neoplasms 21 Ovarian Neoplasms 18 Advanced Breast Cancer 17 Endometrial Neoplasms 11 Prostatic Neoplasms 10 Carcinoma, Non-Small-Cell Lung 10 Hereditary Sensory and Autonomic Neuropathies 8 Triple Negative Breast Neoplasms 5 Multiple Endocrine Neoplasia Type 1 5 Breast Diseases 5 Breast Cancer Metastatic 5 Uterine Cervical Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 4 Recurrence 4 Neoplasms by Site 4 Colorectal Neoplasms 4 Carcinoma, Ovarian Epithelial 4 Small Cell Lung Carcinoma 3 Pancreatic Neoplasms 3 Lung Neoplasms 3 Head and Neck Neoplasms 3 Fallopian Tube Neoplasms 3 Stomach Neoplasms 2 Melanoma 2 Lymphoma, Non-Hodgkin 2 Lymphoma 2 Liposarcoma 2 Hyperglycemia 2

Interventions

Octreotide 6 Irinotecan 6 Loperamide 5 Leucovorin 3 Fluorouracil 3 Calcium Aluminosilicate 3 maltodextrin 2 Probiotics 2 telotristat ethyl 1 shosaiko-to 1 lanreotide 1 isatuximab 1 ceterizine hydrochloride 1 capivasertib 1 cabazitaxel 1 bile acid binding proteins 1 XRP6258 1 Theophylline 1 Temozolomide 1 Surveys and Questionnaires 1 Sulfasalazine 1 Sugars 1 Raloxifene Hydrochloride 1 Radiation 1 Prednisone 1 PHY 906 1 Oxaliplatin 1 Long-Term Synaptic Depression 1 Levofloxacin 1 Lapatinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07426822 2026-02-24

SAFE-CAP

Yale University

Phase 2 Not yet recruiting

Diarrhea, Exanthema

Data powered by HemOnc (CC BY 4.0) Colophon ⚡